Not Dead Yet: Movie & Music to End ALS
Benefitting the Jason Becker Special Needs Trust and ALS Therapy Development
At Bimbo’s 365 Club, September 19, 2013, 7:00 p.m.
September 3, 2013 - San Francisco, CA: Attend a very special screening of the multi award-winning documentary
about the life and music of guitaristextraordinaire Jason Becker, “Jason Becker: Not Dead Yet,” along with live musical performances by
internationally-known hard rock and heavy metal guest musicians, in a benefit
“Not Dead Yet: Movie and Music to End ALS” for the Jason Becker Special Needs
Trustand ALS Therapy Development Institute (ALS TDI), Thursday, September
19, 2013 at Bimbo’s 365 Club. Doors are at 6:30 p.m. with showtime at 7:00 p.m.
In 1990, 20-year old guitarist
extraordinaire Jason Becker, after already recording two full-length albums of
his own, was selected to play guitar for David
Lee Roth - a position previously held by two of the greatest guitarists
ever; Steve Vai and Edward Van Halen. Jason went on to record DLR’s third solo
album, A Little Ain’t Enough, released in April 1991, was voted Best
New Talent by Guitar Magazine by April of the very same year, and was about to begin a world tour that would
make him an international guitar superstar when Becker
began to feel what he called a "lazy limp" in his left leg. Doctors
who soon diagnosed him with Amyotrophic
Lateral Sclerosis (ALS; Lou Gehrig's
Disease) said, not only would never make music again, he wouldn’t live to see his
25th birthday. Over two decades later, now confined to a wheelchair
and without the ability to move or speak, Jason – considered by many to
be the ‘Stephen Hawking of music’ - is very much alive and making music via the
computer he controls only with his eyes.
Join Jason Becker and musical friends
in a very special celebration of his life and music, with musical performances
during intermission and after the screening by Pearl Aday and her band, Pearl, featuring
guitarist (and husband) Scott Ian of Anthrax, guitarist Jim Wilson of Mother Superior and Henry
Rollins’ Rollins Band, bassist Joey Vera of Armored
Saint and Fates Warning, the San Francisco Bay
Day, and special guests.
$50 General Admission tickets include
a light dinner buffet (while supplies last) and $75 VIP tickets include the
dinner buffet, as well as reserved seating, a signed event poster and a meet
and greet with Jason Becker and all the participating musicians.
What: Not Dead Yet: Movie and Music to End ALS made possible by a contribution from Cytokinetics
Where: Bimbo’s 365 Club,
1025 Columbus Ave., San Francisco, CA 94133. http://www.bimbos365club.com. For
General Information Call: 415-474-0365 or email email@example.com
When: Thursday, September 19, 2013, doors
at 6:30 p.m. Showtime at 7:00 p.m.
Tickets: $50 GA and $75 VIP.
Order Link: http://www.bimbos365club.com/event/352927-jason-beckers-not-dead-yet-san-francisco/
Directions: Google Maps: http://goo.gl/maps/k4IMY
info about “Jason Becker: Not Dead Yet” and to watch a preview, please visit: http://www.jasonbeckermovie.com. For
special discounted ticket offers to, and other announcements about, “Not Dead
Yet: Movie and Music to End ALS,” please follow on Facebook at: https://www.facebook.com/JasonBeckerMovie - visit http://www.jasonbecker.com to
hear and purchase Jason Becker’s music.
info or to arrange an interview with any of the participating musicians, please
contact Christopher Buttner at 415-233-7350 or email: firstname.lastname@example.org
Cytokinetics is a
clinical-stage biopharmaceutical company focused on the discovery and
development of novel small molecule therapeutics that modulate muscle function
for the potential treatment of serious diseases and medical conditions. Cytokinetics currently is studying tirasemtiv in a Phase IIb clinical trial for the potential
treatment of amyotrophic lateral sclerosis. Additional information about
Cytokinetics can be obtained at http://www.cytokinetics.com.
About ALS Therapy Development Institute (ALS TDI)
The mission of the ALS
Therapy Development Institute (ALS TDI), http://www.als.net/is
to develop effective therapeutics that slow or stop amyotrophic lateral
sclerosis (ALS, Lou
Gehrig's disease) for patients today. For more info, please contact Mike
Shannon, Development Director, at email@example.com or call 415-694-0663